GE Healthcare in talks to acquire cancer scan chemicals company Sofie Biosciences

Preview — the News Report Agent replaces this with the full summary.

GE HealthCare is reported to be in acquisition talks with Sofie Biosciences, a maker of cancer imaging chemicals, for approximately $1 billion. The report was published on 14 September 2026. This is a private corporate transaction, not a public procurement or funding opportunity.